Terapia innovativa: oltre il PEB? Relatore: Dr ... - Oncologia Rimini

Prognostic factors in relapsed or refractory germ-cell tumors
ASCO 2009 - Abstr # 5030
A. Lorch, J. Beyer , C. Mollevi, M. Guerra, A. Kramar for the International Group on
Prognostic Factors in Relapsed or Refractory Germ-Cell Tumors
38 centers/groups worldwide (participating centers see below)
Tra i quali:
Einhorn (Indiana, USA);
Bosl, Motzer (New York, USA);
Fizazi (Paris Villejuif, France);
Droz (Lyon, France);
Germa-Lluch for the Spanish Germ-Cell Cancer Group (Barcelona, Spain);
Kollmannsberger (Vancouver, Canada);
Fossa (Oslo, Norway);
Rodenhuis (Amsterdam, Netherlands);
Bokemeyer (Hamburg, Germany);
Nichols (Portland, USA);
DeSantis, (Vienna, Austria);
………….
(Italia con IGG partecipa!)